Literature DB >> 18839435

Expansion of hematopoietic stem/progenitor cells.

Wu Hai-Jiang1, Deng Xin-Na, Duan Hui-Jun.   

Abstract

Hematopoietic stem/progenitor cells (HSPCs) transplantation is hampered by the low number of stem cells per sample. To tackle this obstacle, several protocols for expansion of HSPCs in vitro are currently in development, such as the use of cytokine cocktails, coculture with mesenchymal stem cells as feeder cells, and cell culture in bioreactors. With the progress in the understanding of the molecular and cellular mechanisms regulating HSPCs maintenance and expansion, more recent approaches have involved transcription regulation, cell cycle regulation, telomerase regulation, and chromatin-modifying agents. The potential clinical application and safety issues relevant to the expanded HSPCs are also discussed in this review. Copyright 2008 Wiley-Liss, Inc.

Mesh:

Substances:

Year:  2008        PMID: 18839435     DOI: 10.1002/ajh.21262

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  10 in total

1.  A functional screen to identify novel effectors of hematopoietic stem cell activity.

Authors:  Eric Deneault; Sonia Cellot; Amélie Faubert; Jean-Philippe Laverdure; Mélanie Fréchette; Jalila Chagraoui; Nadine Mayotte; Martin Sauvageau; Stephen B Ting; Guy Sauvageau
Journal:  Cell       Date:  2009-04-17       Impact factor: 41.582

Review 2.  Process challenges relating to hematopoietic stem cell cultivation in bioreactors.

Authors:  Marcin Kowalczyk; Kathryn Waldron; Penia Kresnowati; Michael K Danquah
Journal:  J Ind Microbiol Biotechnol       Date:  2011-03-09       Impact factor: 3.346

3.  Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells.

Authors:  Zahra Sadat Hashemi; Mehdi Forouzandeh Moghadam; Masoud Soleimani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-25       Impact factor: 2.416

4.  Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells.

Authors:  David M Harris; Inbal Hazan-Haley; Kevin Coombes; Carlos Bueso-Ramos; Jie Liu; Zhiming Liu; Ping Li; Murali Ravoori; Lynne Abruzzo; Lin Han; Sheela Singh; Michael Sun; Vikas Kundra; Razelle Kurzrock; Zeev Estrov
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

Review 5.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

Review 6.  Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer.

Authors:  Robert R Jenq; Marcel R M van den Brink
Journal:  Nat Rev Cancer       Date:  2010-02-19       Impact factor: 60.716

7.  Three-Dimension Co-culture of Hematopoietic Stem Cells and Differentiated Osteoblasts on Gallic Acid Grafted-Chitosan Scaffold as a Model of Hematopoietic Stem Cells Niche.

Authors:  Jin Wang; Minghao Xiong; Qihao Sun; Wen-Song Tan; Haibo Cai
Journal:  Stem Cell Rev Rep       Date:  2022-01-05       Impact factor: 5.739

Review 8.  Hematopoietic stem cells: ex-vivo expansion and therapeutic potential for myocardial ischemia.

Authors:  Jingwei Lu; Vincent J Pompili; Hiranmoy Das
Journal:  Stem Cells Cloning       Date:  2010-03-30

9.  Comparison of the Ex Vivo Expansion of UCB-Derived CD34+ in 3D DBM/MBA Scaffolds with USSC as a Feeder Layer.

Authors:  Zahra Sadat Hashemi; Mahdi Forouzandeh Moghadam; Masoud Soleimani
Journal:  Iran J Basic Med Sci       Date:  2013-10       Impact factor: 2.699

10.  Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD/SCID/IL2rγnull Mice by Lentiviral Expression of NUP98-HOXA10HD.

Authors:  Allistair Abraham; Yoon-Sang Kim; Huifen Zhao; Keith Humphries; Derek A Persons
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.